| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:2304.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
-Protein Kinase C Protects Against Reperfusion Injury of the Ischemic Heart In Vivo
From the Departments of Molecular Pharmacology (K. Inagaki, L.C., D.M.-R.), Cardiovascular Medicine (F.I., F.H.L., M.R., P.G.Y.), and Comparative Medicine (D.M.B.), Stanford University School of Medicine, Stanford, Calif; and the Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC (K. Imahashi, E.M.).
Correspondence to Daria Mochly-Rosen, Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA 94305-5174. E-mail mochly{at}stanford.edu
Received August 8, 2003; revision received September 19, 2003; accepted September 22, 2003.
Background Current treatment for acute myocardial infarction (AMI) focuses on reestablishing blood flow (reperfusion). Paradoxically, reperfusion itself may cause additional injury to the heart. We previously found that
-protein kinase C (
PKC) inhibition during simulated ischemia/reperfusion in isolated rat hearts is cardioprotective. We focus here on the role for
PKC during reperfusion only, using an in vivo porcine model of AMI.
Methods and Results An intracoronary application of a selective
PKC inhibitor to the heart at the time of reperfusion reduced infarct size, improved cardiac function, inhibited troponin T release, and reduced apoptosis. Using 31P NMR in isolated perfused mouse hearts, we found a faster recovery of ATP levels in hearts treated with the
PKC inhibitor during reperfusion only.
Conclusions Reperfusion injury after cardiac ischemia is mediated, at least in part, by
PKC activation. This study suggests that including a
PKC inhibitor at reperfusion may improve the outcome for patients with AMI.
Key Words: reperfusion cardioprotection kinases
This article has been cited by other articles:
![]() |
A. Prasad, G. W. Stone, D. R. Holmes, and B. Gersh Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The "Dark Side" of Reperfusion Circulation, November 24, 2009; 120(21): 2105 - 2112. [Full Text] [PDF] |
||||
![]() |
E. N. Churchill, J. C. Ferreira, P. C. Brum, L. I. Szweda, and D. Mochly-Rosen Ischaemic preconditioning improves proteasomal activity and increases the degradation of {delta}PKC during reperfusion Cardiovasc Res, November 14, 2009; (2009) cvp334v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu and D. C. Kem Proteasome inhibition during myocardial infarction Cardiovasc Res, October 4, 2009; (2009) cvp309v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Jones, G.-C. Fan, S. Liao, J.-M. Zhang, Y. Wang, N. L. Weintraub, E. G. Kranias, J. E. Schultz, J. Lorenz, and X. Ren Peripheral Nociception Associated With Surgical Incision Elicits Remote Nonischemic Cardioprotection Via Neurogenic Activation of Protein Kinase C Signaling Circulation, September 15, 2009; 120(11_suppl_1): S1 - S9. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chari, T. Getz, B. Nagy Jr, K. Bhavaraju, Y. Mao, Y. S. Bynagari, S. Murugappan, K. Nakayama, and S. P. Kunapuli Protein Kinase C{delta} Differentially Regulates Platelet Functional Responses Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen Ethanol for cardiac ischemia: the role of protein kinase c Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483. [Abstract] [PDF] |
||||
![]() |
T. Nguyen, M. Ogbi, and J. A. Johnson Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi and D. Mochly-Rosen The PKC{delta} -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis J. Cell Sci., March 15, 2008; 121(6): 804 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
Direct Inhibition of {delta}-Protein Kinase C Enzy Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation, February 19, 2008; 117(7): 886 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gundewar, J. W. Calvert, J. W. Elrod, and D. J. Lefer Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2462 - H2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Guo, T. Nguyen, M. Ogbi, H. Tawfik, G. Ma, Q. Yu, R. W. Caldwell, and J. A. Johnson Protein kinase C-{varepsilon} coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2219 - H2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Tuzcu, R. C. Starling, and J. D. Thomas Highlights of the 56th Annual Scientific Session of the American College of Cardiology, March 24-27, 2007. ACC.07 and i2 Summit Highlights: A Conversation With the Experts. J. Am. Coll. Cardiol., August 21, 2007; 50(8 Suppl): C2 - 31. [Full Text] [PDF] |
||||
![]() |
G. Karagulova, Y. Yue, A. Moreyra, M. Boutjdir, and I. Korichneva Protective Role of Intracellular Zinc in Myocardial Ischemia/Reperfusion Is Associated with Preservation of Protein Kinase C Isoforms J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ikeno, K. Inagaki, M. Rezaee, and D. Mochly-Rosen Impaired perfusion after myocardial infarction is due to reperfusion-induced {delta}PKC-mediated myocardial damage Cardiovasc Res, March 1, 2007; 73(4): 699 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kheifets, R. Bright, K. Inagaki, D. Schechtman, and D. Mochly-Rosen Protein Kinase C {delta} ({delta}PKC)-Annexin V Interaction: A REQUIRED STEP IN {delta}PKC TRANSLOCATION AND FUNCTION J. Biol. Chem., August 11, 2006; 281(32): 23218 - 23226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mukherjee, K. A. Apple, C. E. Squires, B. S. Kaplan, J. E. McLean, S. M. Saunders, R. E. Stroud, and F. G. Spinale Protein Kinase C Isoform Activation and Endothelin-1 Mediated Defects in Myocyte Contractility After Cardioplegic Arrest and Reperfusion Circulation, July 4, 2006; 114(1_suppl): I-308 - I-313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Webster Puma joins the battery of BH3-only proteins that promote death and infarction during myocardial ischemia Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H20 - H22. [Full Text] [PDF] |
||||
![]() |
K. Inagaki, E. Churchill, and D. Mochly-Rosen Epsilon protein kinase C as a potential therapeutic target for the ischemic heart Cardiovasc Res, May 1, 2006; 70(2): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Philipp, X.-M. Yang, L. Cui, A. M. Davis, J. M. Downey, and M. V. Cohen Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade Cardiovasc Res, May 1, 2006; 70(2): 308 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zatta, H. Kin, G. Lee, N. Wang, R. Jiang, R. Lust, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling Cardiovasc Res, May 1, 2006; 70(2): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kenessey, E. A. Sullivan, and K. Ojamaa Nuclear localization of protein kinase C-{alpha} induces thyroid hormone receptor-{alpha}1 expression in the cardiomyocyte Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H381 - H389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bright and D. Mochly-Rosen The Role of Protein Kinase C in Cerebral Ischemic and Reperfusion Injury Stroke, December 1, 2005; 36(12): 2781 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Obal, S. Dettwiler, C. Favoccia, H. Scharbatke, B. Preckel, and W. Schlack The Influence of Mitochondrial KATP-Channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat In Vivo Anesth. Analg., November 1, 2005; 101(5): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Churchill, C. L. Murriel, C.-H. Chen, D. Mochly-Rosen, and L. I. Szweda Reperfusion-Induced Translocation of {delta}PKC to Cardiac Mitochondria Prevents Pyruvate Dehydrogenase Reactivation Circ. Res., July 8, 2005; 97(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bloch-Shilderman, T. Kadar, A. Levy, R. Sahar, I. Rabinovitz, and E. Gilat Subcellular Alterations of Protein Kinase C Isozymes in the Rat Brain after Organophosphate Poisoning J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Robinet, G. Hoizey, and H. Millart PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of {beta}1-adrenergic preconditioning Cardiovasc Res, June 1, 2005; 66(3): 530 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanaka, F. Gunawan, R. D. Terry, K. Inagaki, A. D. Caffarelli, G. Hoyt, P. S. Tsao, D. Mochly-Rosen, and R. C. Robbins Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1160 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. He, K. J. Way, E. Arikawa, E. Chou, D. M. Opland, A. Clermont, K. Isshiki, R. C. W. Ma, J. A. Scott, F. J. Schoen, et al. Differential Regulation of Angiotensin II-induced Expression of Connective Tissue Growth Factor by Protein Kinase C Isoforms in the Myocardium J. Biol. Chem., April 22, 2005; 280(16): 15719 - 15726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neckar, I. Markova, F. Novak, O. Novakova, O. Szarszoi, B. Ost'adal, and F. Kolar Increased expression and altered subcellular distribution of PKC-{delta} in chronically hypoxic rat myocardium: involvement in cardioprotection Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1566 - H1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inagaki, R. Begley, F. Ikeno, and D. Mochly-Rosen Cardioprotection by {epsilon}-Protein Kinase C Activation From Ischemia: Continuous Delivery and Antiarrhythmic Effect of an {epsilon}-Protein Kinase C-Activating Peptide Circulation, January 4, 2005; 111(1): 44 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Murriel, E. Churchill, K. Inagaki, L. I. Szweda, and D. Mochly-Rosen Protein Kinase C{delta} Activation Induces Apoptosis in Response to Cardiac Ischemia and Reperfusion Damage: A MECHANISM INVOLVING BAD AND THE MITOCHONDRIA J. Biol. Chem., November 12, 2004; 279(46): 47985 - 47991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanaka, R. D. Terry, G. K. Mokhtari, K. Inagaki, T. Koyanagi, T. Kofidis, D. Mochly-Rosen, and R. C. Robbins Suppression of Graft Coronary Artery Disease by a Brief Treatment With a Selective {epsilon}PKC Activator and a {delta}PKC Inhibitor in Murine Cardiac Allografts Circulation, September 14, 2004; 110(11_suppl_1): II-194 - II-199. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bright, A. P. Raval, J. M. Dembner, M. A. Perez-Pinzon, G. K. Steinberg, M. A. Yenari, and D. Mochly-Rosen Protein Kinase C {delta} Mediates Cerebral Reperfusion Injury In Vivo J. Neurosci., August 4, 2004; 24(31): 6880 - 6888. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy Primary and Secondary Signaling Pathways in Early Preconditioning That Converge on the Mitochondria to Produce Cardioprotection Circ. Res., January 9, 2004; 94(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |